Emergence of Novel Long-acting Mono- and Bi-specific IL-2/IL-13 Superkines as Potent Immune Modulators
October 24 - October 25, 2020
Presenter: Dr. Minh To, PhD, Director Preclinical Development, Medicenna Therapeutics, Inc. Abstract #: 200
Abstract #: 200
Session Title: New Therapies in Immuno OncologySupporting Materials
Download Poster 3.4 MB